Cambridge University (UK) will receive £8 million from the Wellcome Trust and the UK Medical Research Council to build a world-leading centre for stem cell biology and medicine. The Cambridge Stem Cell Institute will advance understanding of stem cells and their potential to treat a range of life-threatening conditions that currently have no effective cures.

The new Institute will uniting 30 leading laboratorys with expertise across the three main types of stem cell: embryonic, adult and induced pluripotent cells. Research scientists will work alongside technology specialists and doctors to develop new therapeutic approaches underpinned by a strong base of fundamental stem cell biology. Key areas of research at the Institute include pluripotency, haematopoiesis, epithelial tissues, and neural and cardiovascular stem cells.

It is intended that the Institute will eventually be housed in a purpose-built 8,000 sq m facility to be constructed on the Cambridge Biomedical Research Campus. Located in Cambridge, the Institute is near the largest cluster of biotechnology companies in Europe, allowing unrivalled opportunities for industry collaboration.

For more information.